<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>JNNP blog</provider_name><provider_url>https://blogs.bmj.com/jnnp</provider_url><author_name>Steve Vucic, Web Editor</author_name><author_url>https://blogs.bmj.com/jnnp/author/svucic/</author_url><title>Neurofilament proteins: Biomakers for ALS! - JNNP blog</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="W9nCNIYDPb"&gt;&lt;a href="https://blogs.bmj.com/jnnp/2014/05/02/neurofilament-protein-biomaker-for-als/"&gt;Neurofilament proteins:  Biomakers for ALS!&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://blogs.bmj.com/jnnp/2014/05/02/neurofilament-protein-biomaker-for-als/embed/#?secret=W9nCNIYDPb" width="600" height="338" title="&#x201C;Neurofilament proteins:  Biomakers for ALS!&#x201D; &#x2014; JNNP blog" data-secret="W9nCNIYDPb" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://blogs.bmj.com/jnnp/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><description>Neurofilament proteins, involved in the axonal transport processes, are biomarkers of axonal loss and are elevated in biological tissues, such as plasma and CSF. In ALS, NF levels may be significantly elevated, especially in the CSF. In the March issue of JNNP, Puentes and colleagues report on the utility of NF as a biomarker of [...]Read More...</description><thumbnail_url>http://www.nature.com/ncb/journal/v6/n7/images/ncb0704-569-F1.gif</thumbnail_url></oembed>
